Kiltearn Partners LLP Has $7.66 Million Holdings in Genpact Limited (NYSE:G)

Kiltearn Partners LLP lessened its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 5.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 195,250 shares of the business services provider's stock after selling 11,650 shares during the quarter. Genpact makes up approximately 1.0% of Kiltearn Partners LLP's portfolio, making the stock its 28th largest holding. Kiltearn Partners LLP owned 0.11% of Genpact worth $7,656,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets increased its holdings in shares of Genpact by 78.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 47,957 shares of the business services provider's stock valued at $1,880,000 after acquiring an additional 21,140 shares during the last quarter. Centaurus Financial Inc. acquired a new position in Genpact during the third quarter valued at approximately $159,000. Cerity Partners LLC raised its position in shares of Genpact by 136.4% in the third quarter. Cerity Partners LLC now owns 17,935 shares of the business services provider's stock valued at $703,000 after purchasing an additional 10,349 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in shares of Genpact in the third quarter worth $540,000. Finally, Advisors Asset Management Inc. grew its stake in Genpact by 3.4% in the 3rd quarter. Advisors Asset Management Inc. now owns 6,885 shares of the business services provider's stock valued at $270,000 after buying an additional 226 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 9,000 shares of the company's stock in a transaction on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the sale, the chief executive officer now owns 267,404 shares in the company, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.80% of the stock is currently owned by corporate insiders.

Genpact Stock Up 0.4 %

Shares of NYSE G opened at $46.82 on Wednesday. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $47.98. The firm's 50-day simple moving average is $40.53 and its 200 day simple moving average is $36.66. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The company has a market cap of $8.26 billion, a price-to-earnings ratio of 12.86, a price-to-earnings-growth ratio of 1.61 and a beta of 1.13.

Genpact Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 9th will be given a dividend of $0.1525 per share. The ex-dividend date is Monday, December 9th. This represents a $0.61 dividend on an annualized basis and a dividend yield of 1.30%. Genpact's payout ratio is currently 16.76%.

Wall Street Analyst Weigh In

Several brokerages have commented on G. TD Cowen lifted their price target on Genpact from $40.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, November 8th. Jefferies Financial Group upped their target price on shares of Genpact from $35.00 to $40.00 and gave the company a "hold" rating in a research note on Monday, September 9th. Needham & Company LLC raised their price target on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, November 11th. Robert W. Baird upped their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Finally, BMO Capital Markets increased their target price on shares of Genpact from $38.00 to $42.00 and gave the company a "market perform" rating in a research note on Monday, August 12th. Eight analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $42.33.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.